The University of Hong Kong Clinical Trials Centre (HKU-CTC) is an academic clinical research organization established under The University of Hong Kong (HKU) in 1998 and has been authorized as the central platform for management and coordination of clinical studies under HKU and its affiliated teaching hospital – Queen Mary Hospital (QMH). HKU-CTC is devoted to partnering with clinical investigators, research organizations and the healthcare industry in advancing human healthcare by promoting, attracting and facilitating clinical studies of various natures, such as: - investigator-initiated and industry-sponsored clinical studies; - interventional and non-interventional clinical studies; - clinical studies on various medicinal products including small-molecule chemical drugs, biopharmaceuticals, medical devices, diagnostics, traditional/proprietary Chinese medicines, herbal medicines and health supplements; - phase 1 to 4 clinical trials; and - clinical studies on clinical procedures and methods.